Ftse Mib
33.541,98
-0,49%
DAX
18.155,24
-0,04%
S&P 500
5.477,90
0,16%
NASDAQ
17.805,16
0,49%
Bitcoin
61.066,22
0,42%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cerus Corp (CERS) Cerus Corp (CERS) Notizie

CERS

Cerus (CERS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERS
DataOraFonteTitoloSimboloCompagnia
21/06/202414:30Business WireCerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood TransfusionNASDAQ:CERSCerus Corp
14/06/202414:30Business WireCerus Corporation Celebrates World Blood Donor Day 2024NASDAQ:CERSCerus Corp
11/06/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERSCerus Corp
07/06/202402:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERSCerus Corp
31/05/202422:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CERSCerus Corp
22/05/202414:30Business WireCerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor ConferenceNASDAQ:CERSCerus Corp
02/05/202422:00Business WireCerus Corporation Announces First Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/04/202414:30Business WireCerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024NASDAQ:CERSCerus Corp
26/03/202413:30Business WireCerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeNASDAQ:CERSCerus Corp
19/03/202413:00Business WireCerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery PatientsNASDAQ:CERSCerus Corp
08/03/202422:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERSCerus Corp
05/03/202422:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERSCerus Corp
05/03/202422:00Business WireCerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:CERSCerus Corp
20/02/202414:30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024NASDAQ:CERSCerus Corp
14/02/202422:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CERSCerus Corp
01/02/202414:30Business WireCerus Corporation to Participate in Upcoming Investor ConferencesNASDAQ:CERSCerus Corp
08/01/202414:30Business WireCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business UpdateNASDAQ:CERSCerus Corp
16/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERSCerus Corp
02/11/202322:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CERSCerus Corp
02/11/202322:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CERSCerus Corp
02/11/202321:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERSCerus Corp
02/11/202321:00Business WireCerus Corporation Announces Third Quarter 2023 Financial ResultsNASDAQ:CERSCerus Corp
19/10/202314:30Business WireCerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:CERSCerus Corp
10/10/202314:30Business WireCerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual MeetingNASDAQ:CERSCerus Corp
27/09/202314:30Business WireCerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources OfficerNASDAQ:CERSCerus Corp
12/09/202314:30Business WireCerus Corporation to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:CERSCerus Corp
02/08/202322:00Business WireCerus Corporation Announces Second Quarter 2023 Financial ResultsNASDAQ:CERSCerus Corp
19/07/202314:30Business WireCerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023NASDAQ:CERSCerus Corp
15/06/202314:30Business WireCerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT CongressNASDAQ:CERSCerus Corp
14/06/202314:30Business WireCerus Corporation Celebrates World Blood Donor Day 2023NASDAQ:CERSCerus Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERS

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
SRG
Snam
BIT
LDO
Leonardo
BIT
G
Generali
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network